Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 19 Naples 11 Florence 11 Rome 10 Roma 10
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca138 Merck Sharp & Dohme LLC98 Hoffmann-La Roche81 Novartis Pharmaceuticals73 Clear sponsor filter
Site location
Milan19 Naples11 Florence11 Rome10 Roma10
All 65 locations
Target enrolment
to

Trials with a site in Milan

19 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
84
Naples, Florence, Milan, Padova
2026-10-09
Recruiting
Novo Nordisk A/S
Phase 3
1,778
Chieti, Catanzaro, Naples, Ravenna, Chiavari, Milan, Roma, Lucca
2026-08-24
By invitation
Novo Nordisk A/S
Observational
214
Pescara, San Giovanni in Fiore (CS), Marano Di Napoli (NA), Rome, Milan, Cuneo, Catania, Bolzano
2026-05-28
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
400
Udine, Rome, Milan, San Donato Milanese, Verona
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 3
630
Bologna, Rome, Milan, Palermo
2026-04-13
Recruiting
Novo Nordisk A/S
Phase 3
400
Naples, Modena, Udine, Rome, Milan, San Donato Milanese, Verona
2026-04-13
Recruiting
Novo Nordisk A/S
Phase 3
460
Milan, Novara, Verona, Trieste
2026-01-08
Active, closed
Novo Nordisk A/S
Phase 3
300
Rome, Palermo, Bologna, Milan
2025-11-05
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Novo Nordisk A/S
Phase 4
586
Bari, Catanzaro, Naples, Rome, Milan, Messina, Palermo, Fermo
2025-08-15
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Active, closed
Novo Nordisk A/S
Phase 4
500
Florence, Milan, Roma, Trieste, Verona
2024-09-17
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Rome, Florence, Milan, Naples, Roma, Torino
2023-02-13
Active, closed
Novo Nordisk A/S
Phase 3
412
Milan, Florence, Genova, Naples, Roma, Rome
2022-08-10
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Florence, Milan, Roma, Torino
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Florence, Castelfranco Veneto, Milan, Udine, Verona
2019-10-21
Active, closed
Novo Nordisk A/S
Phase 2
62
Florence, Genova, Milan, Roma
2019-07-04
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Milan that also match the filters currently applied.

How many clinical trials are recruiting in Milan?

8 of the 19 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milan), 19 studies
PhaseStudiesRecruitingShare
Phase 313668.4%
Observational2010.5%
Phase 22110.5%
Phase 42110.5%

Most active sponsors

Lead sponsors with the most studies (Milan)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S198
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.